Clinical Trial Update: Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating whether cognitive behavioral therapy can prolong the antidepressant effects of intravenous ketamine in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Yale University | Conditions: Depression | Phase 1 | Status: COMPLETED